FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904508814> ?p ?o ?g. }

• W2904508814 abstract "Although the mechanisms underlying AD neurodegeneration are not fully understood, it is now recognised that inflammation could play a crucial role in the initiation and progression of AD neurodegeneration. A neuro-inflammatory network, based on the anomalous activation of microglial cells, includes the production of a number of inflammatory cytokines both locally and systemically. These may serve as diagnostic markers or therapeutic targets for AD neurodegeneration. We have measured the levels of the inflammation-related cytokines and receptors of the IL-1 family in serum of subjects with AD, compared to mild cognitive impairment (MCI), subjective memory complaints (SMC), and normal healthy subjects (NHS). Using a custom-made multiplex ELISA array, we examined ten factors of the IL-1 family, the inflammation-related cytokines IL-1α, IL-1β, IL-18, and IL-33, the natural inhibitors IL-1Ra and IL-18BP, and the soluble receptors sIL-1R1, sIL-1R2, sIL-1R3, and sIL-1R4. The inflammatory cytokines IL-1α and IL-1β, their antagonist IL-1Ra, and their soluble receptor sIL-1R1 were increased in AD. The decoy IL-1 receptor sIL-1R2 was only increased in MCI. IL-33 and its soluble receptor sIL-1R4 were also significantly higher in AD. The soluble form of the accessory receptor for both IL-1 and IL-33 receptor complexes, sIL-1R3, was increased in SMC and even more in AD. Total IL-18 levels were unchanged, whereas the inhibitor IL-18BP was significantly reduced in MCI and SMC, and highly increased in AD. The levels of free IL-18 were significantly higher in MCI. AD is characterised by a significant alteration in the circulating levels of the cytokines and receptors of the IL-1 family. The elevation of sIL-1R4 in AD is in agreement with findings in other diseases and can be considered a marker of ongoing inflammation. Increased levels of IL-1Ra, sIL-1R1, sIL-1R4, and IL-18BP distinguished AD from MCI and SMC, and from other inflammatory diseases. Importantly, sIL-1R1, sIL-1R3, sIL-1R4, and IL-18BP negatively correlated with cognitive impairment. A significant elevation of circulating sIL-1R2 and free IL-18, not present in SMC, is characteristic of MCI and disappears in AD, making them additional interesting markers for evaluating progression from MCI to AD." @default.
• W2904508814 created "2018-12-22" @default.
• W2904508814 creator A5015691877 @default.
• W2904508814 creator A5017765100 @default.
• W2904508814 creator A5020662037 @default.
• W2904508814 creator A5024513740 @default.
• W2904508814 creator A5055365161 @default.
• W2904508814 creator A5056038136 @default.
• W2904508814 creator A5056354047 @default.
• W2904508814 creator A5057246307 @default.
• W2904508814 creator A5057996230 @default.
• W2904508814 creator A5069596940 @default.
• W2904508814 creator A5071826620 @default.
• W2904508814 date "2018-12-01" @default.
• W2904508814 modified "2023-10-10" @default.
• W2904508814 title "Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression?" @default.
• W2904508814 cites W1479801731 @default.
• W2904508814 cites W1885840961 @default.
• W2904508814 cites W1964417277 @default.
• W2904508814 cites W1965942744 @default.
• W2904508814 cites W1968155895 @default.
• W2904508814 cites W1972982304 @default.
• W2904508814 cites W1973445155 @default.
• W2904508814 cites W1977135749 @default.
• W2904508814 cites W1983312277 @default.
• W2904508814 cites W1997884858 @default.
• W2904508814 cites W1998535349 @default.
• W2904508814 cites W2008617310 @default.
• W2904508814 cites W2008870493 @default.
• W2904508814 cites W2014788740 @default.
• W2904508814 cites W2015186493 @default.
• W2904508814 cites W2017079501 @default.
• W2904508814 cites W2024334393 @default.
• W2904508814 cites W2026161448 @default.
• W2904508814 cites W2032679768 @default.
• W2904508814 cites W2040791183 @default.
• W2904508814 cites W2043679754 @default.
• W2904508814 cites W2048253779 @default.
• W2904508814 cites W2054789459 @default.
• W2904508814 cites W2063166582 @default.
• W2904508814 cites W2071695496 @default.
• W2904508814 cites W2072442310 @default.
• W2904508814 cites W2075539642 @default.
• W2904508814 cites W2079873627 @default.
• W2904508814 cites W2081030580 @default.
• W2904508814 cites W2084242485 @default.
• W2904508814 cites W2098631023 @default.
• W2904508814 cites W2100122484 @default.
• W2904508814 cites W2102758774 @default.
• W2904508814 cites W2115017507 @default.
• W2904508814 cites W2117813875 @default.
• W2904508814 cites W2150551517 @default.
• W2904508814 cites W2159704527 @default.
• W2904508814 cites W2166336042 @default.
• W2904508814 cites W2166447559 @default.
• W2904508814 cites W2270215994 @default.
• W2904508814 cites W2342031861 @default.
• W2904508814 cites W2486242608 @default.
• W2904508814 cites W2524111180 @default.
• W2904508814 cites W2534771646 @default.
• W2904508814 cites W2547214152 @default.
• W2904508814 cites W2582524520 @default.
• W2904508814 cites W2585474145 @default.
• W2904508814 cites W2614736523 @default.
• W2904508814 cites W2744015013 @default.
• W2904508814 cites W2746613376 @default.
• W2904508814 cites W2748400555 @default.
• W2904508814 cites W2771968994 @default.
• W2904508814 cites W2780744144 @default.
• W2904508814 cites W2781447571 @default.
• W2904508814 cites W2797969237 @default.
• W2904508814 cites W4302415854 @default.
• W2904508814 doi "https://doi.org/10.1186/s12974-018-1376-1" @default.
• W2904508814 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6292179" @default.
• W2904508814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30541566" @default.
• W2904508814 hasPublicationYear "2018" @default.
• W2904508814 type Work @default.
• W2904508814 sameAs 2904508814 @default.
• W2904508814 citedByCount "82" @default.
• W2904508814 countsByYear W29045088142019 @default.
• W2904508814 countsByYear W29045088142020 @default.
• W2904508814 countsByYear W29045088142021 @default.
• W2904508814 countsByYear W29045088142022 @default.
• W2904508814 countsByYear W29045088142023 @default.
• W2904508814 crossrefType "journal-article" @default.
• W2904508814 hasAuthorship W2904508814A5015691877 @default.
• W2904508814 hasAuthorship W2904508814A5017765100 @default.
• W2904508814 hasAuthorship W2904508814A5020662037 @default.
• W2904508814 hasAuthorship W2904508814A5024513740 @default.
• W2904508814 hasAuthorship W2904508814A5055365161 @default.
• W2904508814 hasAuthorship W2904508814A5056038136 @default.
• W2904508814 hasAuthorship W2904508814A5056354047 @default.
• W2904508814 hasAuthorship W2904508814A5057246307 @default.
• W2904508814 hasAuthorship W2904508814A5057996230 @default.
• W2904508814 hasAuthorship W2904508814A5069596940 @default.
• W2904508814 hasAuthorship W2904508814A5071826620 @default.
• W2904508814 hasBestOaLocation W29045088141 @default.
• W2904508814 hasConcept C126322002 @default.
• W2904508814 hasConcept C134018914 @default.
• W2904508814 hasConcept C164027704 @default.

• next